Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis

Journal of Hepatology

Volumn 49, Issue 1, 2008, Pages 25-33

  Yang, Ying Ying ^a,b   Lee, Kuei Chuan ^a,b   Huang, Yi Tsau ^b   Wang, Ying Wen ^a,b   Hou, Ming Chih ^a,b   Lee, Fa Yauh ^a,b   Lin, Han Chieh ^a,b   Lee, Shou Dong ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Anti oxidants; Intrahepatic resistance; N Acetylcysteine; Nitrotyrosilation

Indexed keywords

3 NITROTYROSINE; ACETYLCYSTEINE; ANTIOXIDANT; COLLAGEN TYPE 3; LIVER PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; NITRIC OXIDE; OXIDIZING AGENT; THROMBOXANE A2; THROMBOXANE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BILE DUCT LIGATION; BILIARY CIRRHOSIS; CONTROLLED STUDY; DRUG EFFECT; FIBROGENESIS; LIVER; LIVER CIRCULATION; LIVER PERFUSION; MALE; MICROCIRCULATION; NITROTYROSILATION; NONHUMAN; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RAT;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; BILE DUCTS; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; LIGATION; LIVER CIRCULATION; LIVER CIRRHOSIS, BILIARY; LIVER FUNCTION TESTS; MALE; MICROCIRCULATION; OXIDANTS; PEPTIDE FRAGMENTS; PROCOLLAGEN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUPEROXIDE DISMUTASE; THROMBOXANE-A SYNTHASE; TYROSINE; VASCULAR RESISTANCE;

EID: 44649155781     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.02.012     Document Type: Article

References (40)

1. Sherlock S. Chronic hepatitis and cirrhosis. Hepatology 4 (1984) S25-S28
2. Sikuler E., Kravetz D., and Groszmann R.J. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 248 (1985) G618-G625
3. Natarajan S.K., Thomas S., Ramamoorthy P., Basivireddy J., Pulimood A.B., Ramachandran A., et al. Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models. J Gastroenterol Hepatol 21 (2006) 947-957
4. Muriel P. Peroxidation of lipids and liver damage. In: Baskia S.I., and Salem H. (Eds). Oxidants, antioxidants, and free radicals (1997), Taylor & Francis, Washington, USA 237-257
5. Parola M., and Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol 35 (2001) 297-306
6. Singh S., Shackleton G., Ah-Sing E., Chakraborty J., and Bailey M.E. Antioxidant defenses in the bile duct-ligated rat. Gastroenterology 103 (1992) 1625-1629
7. Bianchi G., Marchesini G., Fabbri A., Ronchi M., Chianese R., and Grossi G. Lipoperoxide plasma levels in patients with liver cirrhosis. Hepatogastroenterology 44 (1997) 784-788
8. Rockey D.C. Vascular mediators in the injured liver. Hepatology 37 (2003) 4-12
9. Gupta T.K., Toruner M., Chung M.K., and Groszmann R.J. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 28 (1998) 926-931
10. Shah V., Toruner M., Haddad F., Cadelina G., Papapetropoulos A., Choo K., et al. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in rat. Gastroenterology 117 (1999) 1222-1228
11. Handy D.E., and Loscalzo J. Nitric oxide and posttranslational modification of the vascular proteome: S-nitration of reactive thiols. Arterioscler Thromb Vasc Biol 26 (2006) 1207-1214
12. Wiest R., and Groszmann R.J. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 35 (2002) 478-491
13. Hernandez Guerra M., Garcia-Pagan J.C., Turnes J., Bellot P., Deulofeu R., Abraldes J.G., et al. Ascorbic acid improves the intrahepatic endothelial dysfunction in patients with cirrhosis and portal hypertension. Hepatology 43 (2006) 485-491
14. 4 cirrhosis. Hepatology 44 (2006) 44-52
15. Graupera M., Garcǐa-Pagan J.C., Pares M., Abraldes J.G., Rosello J., Bosch J., et al. Cycloxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers. J Hepatol 39 (2003) 515-521
16. Rodri{dotless}́guez-Vilarrupla A., Bosch J., and Garci{dotless}́a-Pagán J.C. Potential role of antioxidants in the treatment of portal hypertension. J Hepatol 46 (2007) 193-197
17. Zwingmann C., and Bilodeau M. Metabolic insights into the hepatoprotective role of N-acetylcysteine in mouse liver. Hepatology 43 (2006) 454-463
18. Harrison P.M., Wendon J.A., Gimson A.E., Alexander G.J., and Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminate hepatic failure. N Engl J Med 324 (1991) 1852-1857
19. Jones A.L., Bangash I.H., Bouchier I.A., and Hayes P.C. Portal and systemic haemodynamic action of N-acetylcysteine in patients with stable cirrhosis. Gut 35 (1994) 1290-1293
20. Mani A.R., Ippolito S., Ollosson R., and Moore K.P. Nitration of cardiac proteins is associated with abnormal cardiac chronotropic responses in rats with biliary cirrhosis. Hepatology 43 (2006) 847-856
21. Fernando B., Marley R., Holt S., Anand R., Harry D., Sanderson P., et al. N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rats. Hepatology 28 (1998) 689-694
22. Lin H.C., Huang Y.T., Wu H.L., Lee W.C., Hou M.C., Lee F.Y., et al. Effect of sustained release lanreotide on hemodynamics in rats with portal vein stenosis. J Hepatol 31 (1999) 482-488
23. Lin H.C., Huang Y.T., Wei H.C., Yang Y.Y., Lee T.Y., Wang Y.W., et al. Hemodynamic effects of one-week carvedilol administration on cirrhotic rats. J Gastroenterol 41 (2006) 361-368
24. 1 cannabinoid receptor antagonism on livers of rats with biliary cirrhosis. Clin Sci 112 (2007) 533-542
25. Yang Y.Y., Lin H.C., Huang Y.T., Lee T.Y., Lee W.C., Hou M.C., et al. Adaptive vasodilatory response after octreotide treatment. Am J Physiol Gastrointest Liver Physiol 281 (2001) G117-G123
26. Perner A., Andressen L., Normark M., Fischer-Hansen B., Sorensen S., Eugen-Olsen J., et al. Expression of nitric oxide synthases and effects of l-arginine and l-NMMA on nitric oxide production and fluid transport in collagen colitis. Gut 49 (2001) 387-394
27. Pastor A., Collado P.S., Almar H., and Gonzalez-Gallego J. Antioxidant enzyme status in biliary obstructed rats: effects of N-acetylcysteine. J Hepatol 27 (1997) 363-370
28. Huang Y.T., Hsu Y.C., Chen C.J., Liu C.T., and Wei Y.H. Oxidative-stress-related changes in the livers of bile duct-ligated rats. J Biomed Sci 10 (2003) 170-178
29. Chang T.T., Lin H.C., Lee S.D., Tsai Y.T., Lee F.Y., Jeng F.S., et al. Clinical significance of serum type-III procollagen aminopropeptide in hepatitis B virus-related liver diseases. Scand J Gastroenterol 24 (1989) 533-538
30. Buck M., Kim D.J., Houglum K., Hassanein T., and Chojkier M. c-Myb modulates transcription of the alpha-smooth muscle actin gene in activated hepatic stellate cell. Am J Physiol Gastrointest Liver Physiol 278 (2000) G321-G328
31. Ye Y., Lin Y., Atar S., Huang M.H., Perez-Polo J.R., Uretsky B.F., et al. Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions. Am J Physiol Heart Circ Physiol 291 (2006) H1158-H1169
32. Trebicka J., Hennenberg M., Laleman W., Shelest N., Biecker E., Schepke M., et al. Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of Rho/Rho-kinase and activation of endothelial nitric oxide synthase. Hepatology 46 (2007) 242-253
33. Koeppel T.A., Thies J.C., Lehmann T., Gebhard M.M., Herfarth C., Otto G., et al. Improvement of hepatic microhemodynamics by N-acetylcysteine after warm ischemia. Eur Surg Res 28 (1996) 270-277
34. Cailleret M., Amadou A., Andrieu-Abadie N., Nawrocki A., Adamy C., Ait-Mamer B., et al. N-acetylcysteine prevents the deleterious effect of tumor necrosis factor-(alpha) on calcium transients and contraction in adult rat cardiomyocytes. Circulation 109 (2004) 406-411
35. Kigawa G., Nakano H., Kumada K., Kitamura N., Takeuchi S., Hatakeyama T., et al. Improvement of portal flow and hepatic microcirculatory tissue flow with N-acetylcysteine in dogs with obstructive jaundice produced by bile duct ligation. Eur J Surg 166 (2000) 77-84
36. Navarro-Antolin J., Redondo-Horcajo M., Zaragoza C., Alvarez-Barrientos A., Fernandez A.P., Leon-Gomez E., et al. Role of peroxynitrite in endothelial damage mediated by Cyclosporine A. Free Radic Biol Med 42 (2007) 394-403
37. Barreiro E., Galdiz J.B., Marinan M., Alvarez F.J., Hussain N.A., and Gea J. Respiratory loading intensity and diaphragm oxidative stress: N-acetylcysteine effects. J Appl Physiol 100 (2006) 555-563
38. Dudenhoefer A.A., Loureiro-Silva M.R., Cadelina G.W., Gupta T., and Groszmann R.J. Bioactivation of nitroglycerin and vasomotor response to nitric oxide are impaired in cirrhotic rat livers. Hepatology 36 (2002) 381-385
39. Kawada N., Seki S., Inoue M., and Kuroki T. Effect of antioxidants, resveratrol, quercetin and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and kupffer cells. Hepatology 27 (1998) 1265-1674
40. Rojkind M., Gambrone M.A., and Biempica L. Collagen types in normal and cirrhotic liver. Gastroenterology 76 (1979) 710-719